Hyphens Pharma International (SGX:1J5) Debt-to-Asset : 0.04 (As of Jun. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Hyphens Pharma International Debt-to-Asset?

Hyphens Pharma International's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was S$1.9 Mil. Hyphens Pharma International's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was S$2.7 Mil. Hyphens Pharma International's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2023 was S$115.3 Mil. Hyphens Pharma International's debt to asset for the quarter that ended in Jun. 2023 was 0.04.

Hyphens Pharma International Debt-to-Asset Historical Data

The historical data trend for Hyphens Pharma International's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hyphens Pharma International Debt-to-Asset Chart

Hyphens Pharma International Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Debt-to-Asset

Get a 7-Day Free Trial

0.04

0.06

0.08

0.05

Hyphens Pharma International Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Debt-to-Asset	Get a 7-Day Free Trial										0.05	0.08	0.05	0.05	0.04

Competitive Comparison of Hyphens Pharma International's Debt-to-Asset

For the Pharmaceutical Retailers subindustry, Hyphens Pharma International's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hyphens Pharma International's Debt-to-Asset Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Hyphens Pharma International's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Hyphens Pharma International's Debt-to-Asset falls into.

Hyphens Pharma International Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Hyphens Pharma International's Debt-to-Asset for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(2.34	+	3.33)	/	114.469
	=	0.05

Hyphens Pharma International's Debt-to-Asset for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.874	+	2.651)	/	115.331
	=	0.04

Hyphens Pharma International (SGX:1J5) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Hyphens Pharma International Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Hyphens Pharma International's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Hyphens Pharma International (SGX:1J5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Hyphens Pharma International Ltd (SGX:1J5) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

16 Tai Seng Street, Level 4, Singapore, SGP, 534138

Website

https://www.hyphensgroup.com

Hyphens Pharma International Ltd is a pharmaceutical company. Its segments include Specialty Pharma Principals segment; Proprietary Brands segment and Medical Hypermart and Digital segment. Specialty pharma principals segment engages in the business of selling and marketing specialty pharmaceutical products. Proprietary Brands segment develops, markets and sells own proprietary range of dermatological products and health supplement products through Hyphens and Ocean Health Singapore. Medical Hypermart and Digital is engaged in the wholesale of pharmaceuticals and medical supplies in Singapore through Pan-Malayan.

Hyphens Pharma International (SGX:1J5) Headlines

No Headlines